Sabra Healthcare REIT Inc (SBRA) 20 Days SMA touches -3.73%: The odds favor the bear

A new trading day began on Friday, with Sabra Healthcare REIT Inc (NASDAQ: SBRA) stock price up 1.71% from the previous day of trading, before settling in for the closing price of $13.43. SBRA’s price has ranged from $10.10 to $14.91 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Real Estate Sector giant was 1.01%. Meanwhile, its annual earnings per share averaged 861.53%. With a float of $227.78 million, this company’s outstanding shares have now reached $231.27 million.

Let’s determine the extent of company efficiency that accounts for 48 employees.

Sabra Healthcare REIT Inc (SBRA) Insider Activity

As we move forward, let’s examine how large-scale investors are investing in this stock of the REIT – Healthcare Facilities Industry. The insider ownership of Sabra Healthcare REIT Inc is 1.60%, while institutional ownership is 91.68%. The most recent insider transaction that took place on Sep 01 ’23, was worth 24,591. In this transaction Executive VP, CFO & Secretary of this company bought 1,947 shares at a rate of $12.63, taking the stock ownership to the 183,218 shares.

Sabra Healthcare REIT Inc (SBRA) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.81 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 861.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.30% during the next five years compared to -47.68% drop over the previous five years of trading.

Sabra Healthcare REIT Inc (NASDAQ: SBRA) Trading Performance Indicators

Here are Sabra Healthcare REIT Inc’s current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.84. Likewise, its price to free cash flow for the trailing twelve months is 10.50.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.06, a number that is poised to hit 0.14 in the next quarter and is forecasted to reach 0.64 in one year’s time.

Technical Analysis of Sabra Healthcare REIT Inc (SBRA)

Looking closely at Sabra Healthcare REIT Inc (NASDAQ: SBRA), its last 5-days average volume was 1.98 million, which is a drop from its year-to-date volume of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 16.57%. Additionally, its Average True Range was 0.28.

During the past 100 days, Sabra Healthcare REIT Inc’s (SBRA) raw stochastic average was set at 39.90%, which indicates a significant increase from 25.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 20.33% in the past 14 days, which was lower than the 21.14% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $14.03, while its 200-day Moving Average is $13.66. However, in the short run, Sabra Healthcare REIT Inc’s stock first resistance to watch stands at $13.75. Second resistance stands at $13.83. The third major resistance level sits at $14.01. If the price goes on to break the first support level at $13.49, it is likely to go to the next support level at $13.31. Should the price break the second support level, the third support level stands at $13.23.

Sabra Healthcare REIT Inc (NASDAQ: SBRA) Key Stats

With a market capitalization of 3.16 billion, the company has a total of 231,477K Shares Outstanding. Currently, annual sales are 647,510 K while annual income is 13,760 K. The company’s previous quarter sales were 163,400 K while its latest quarter income was 17,160 K.